Skip to content

A clinical trial to study the efficacy of vamana , vasti and nasya in artava kshaya(PCOD).

A clinical study on the role of Madanaphala yoga siddha Vamana, Dadimadhya ghrita siddha Matra vasti and Kalyanaka ghrita siddha Nasya in the management of Artava kshaya with special reference to Polycystic Ovarian Disorder - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073956
Enrollment
30
Registered
2024-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

None listed

Sponsors

SV Ayurvedic College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients presenting with signs and symptoms of artava kshaya. patients presenting with signs and symptoms of PCOD by fulfilling rotterdam consensus. patients eligible for vamana, vasti and nasya.

Exclusion criteria

Exclusion criteria: patients below the age of 18 years and above the age of 40 years. patients with uncontrolled diabetes and hypertension. patients with ovarian cancer, TB, other major systemic diseases. patients who are not eligible for vamana, vasti or nasya.

Design outcomes

Primary

MeasureTime frame
appearance of menstruation and reduction in clinical hyperandrogenismTimepoint: at baseline after treatment i.e.,27th -32nd day

Secondary

MeasureTime frame
to prove reduction in no. of follicles & size of ovaries through ultrasonography along with maintaining LH & FSH ratio.Timepoint: during followup after 3 months (90th day) approximately.

Countries

India

Contacts

Public ContactPappuru Lakshmi Prasanna

S.V.Ayurvedic College and Hospital

dr.lpvedantam@gmail.com9440218860

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026